Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Natural and Induced T CD4+CD25+FOXP3+ Regulatory T Cells

  • Protocol
  • First Online:
Suppression and Regulation of Immune Responses

Part of the book series: Methods in Molecular Biology ((MIMB,volume 677))

Abstract

Evidence has been accumulated to show that the forkhead/winged-helix transcription factor Foxp3 is a good marker for specialized CD4+ T cells that regulate immune responses to self as well as to a variety of foreign antigens including infectious or tumor antigens, alloantigens, allergens, and commensal antigens. It is now well established that CD4+CD25+Foxp3+ regulatory T cells encompass two categories of lymphocytes that are distinct in their origin, antigen specificity, as well as the stimuli driving their differentiation and homeostasis. Natural CD4+CD25+Foxp3+ regulatory T cells are an independent lineage generated in the thymus through major histocompatibility class II molecules-dependent MHC class high avidity interactions with their T cell receptor. They are specific for self-antigens. Adaptive or induced CD4+CD25+Foxp3+ regulatory T cells stem from mature CD4+CD25-Foxp3-precursors at the periphery following adequate stimulation. They have been shown to develop in vivo following suboptimal antigen stimulation, in situations characterized by chronic inflammation (autoimmunity, allergy, immune responses to tumors and transplants) and also as physiological actors of the mucosal immune system. Although major progress has been accomplished over the last years in our understanding of the central role of CD4+CD25+Foxp3+ regulatory T cells in the control of immune responses, major issues are still elusive. In particular, there are still no reliable phenotypic or functional markers that make it possible to distinguish between natural and induced CD25+Foxp3+ regulatory T cells.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gershon, R.K., and K. Kondo. 1971. Infec tious immunological tolerance. Immunology 21:903–914.

    PubMed  CAS  Google Scholar 

  2. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151–1164.

    PubMed  CAS  Google Scholar 

  3. Kim, J.M., and A. Rudensky. 2006. The role of the transcription factor Foxp3 in the deve lopment of regulatory T cells. Immunol Rev 212:86–98.

    Article  PubMed  CAS  Google Scholar 

  4. Fontenot, J.D., J.P. Rasmussen, L.M. Williams, J.L. Dooley, A.G. Farr, and A.Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22:329–341.

    Article  PubMed  CAS  Google Scholar 

  5. Chen, W., W. Jin, N. Hardegen, K.J. Lei, L. Li, N. Marinos, G. McGrady, and S.M. Wahl. 2003. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198:1875–1886.

    Article  PubMed  CAS  Google Scholar 

  6. Liang, S., P. Alard, Y. Zhao, S. Parnell, S.L. Clark, and M.M. Kosiewicz. 2005. Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costi mulation, but not the thymus. J Exp Med 201:127–137.

    Article  PubMed  CAS  Google Scholar 

  7. Curotto de Lafaille, M.A., A.C. Lino, N. Kutchukhidze, and J.J. Lafaille. 2004. CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion. J Immunol 173:7259–7268.

    PubMed  CAS  Google Scholar 

  8. Karim, M., C.I. Kingsley, A.R. Bushell, B.S. Sawitzki, and K.J. Wood. 2004. Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25-CD4+ precursors in a thymus-independent process. J Immunol 172:923–928.

    PubMed  CAS  Google Scholar 

  9. Cobbold, S.P., R. Castejon, E. Adams, D. Zelenika, L. Graca, S. Humm, and H. Waldmann. 2004. Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J Immunol 172:6003–6010.

    PubMed  CAS  Google Scholar 

  10. Takahashi, T., T. Tagami, S. Yamazaki, T. Uede, J. Shimizu, N. Sakaguchi, T.W. Mak, and S. Sakaguchi. 2000. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 192:303–310.

    Article  PubMed  CAS  Google Scholar 

  11. Shimizu, J., S. Yamazaki, T. Takahashi, Y. Ishida, and S. Sakaguchi. 2002. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 3:135–142.

    Article  PubMed  CAS  Google Scholar 

  12. Read, S., V. Malmstrom, and F. Powrie. 2000. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 192:295–302.

    Article  PubMed  CAS  Google Scholar 

  13. Tang, Q., and J.A. Bluestone. 2006. Regulatory T-cell physiology and application to treat autoimmunity. Immunol Rev 212:217–237.

    Article  PubMed  CAS  Google Scholar 

  14. You, S., B. Leforban, C. Garcia, J.F. Bach, J.A. Bluestone, and L. Chatenoud. 2007. Adaptive TGF-{beta}-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment. Proc Natl Acad Sci USA 104:6335–6340.

    Article  PubMed  CAS  Google Scholar 

  15. Mchugh, R.S., M.J. Whitters, C.A. Piccirillo, D.A. Young, E.M. Shevach, M. Collins, and M.C. Byrne. 2002. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16:311–323.

    Article  PubMed  CAS  Google Scholar 

  16. Piccirillo, C.A., J.J. Letterio, A.M. Thornton, R.S. Mchugh, M. Mamura, H. Mizuhara, and E.M. Shevach. 2002. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J Exp Med 196:237–246.

    Article  PubMed  CAS  Google Scholar 

  17. You, S., M. Belghith, P. Cobbold, M.A. Alyanakian, C. Gouarin, S. Barriot, C. Garcia, H. Waldmann, L. Chatenoud, and J.F. Bach. 2005. Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T cells. Diabetes 54(5):1415–1422.

    Article  PubMed  CAS  Google Scholar 

  18. Shevach, E.M., R.A. DiPaolo, J. Andersson, D.M. Zhao, G.L. Stephens, and A.M. Thornton. 2006. The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells. Immunol Rev 212:60–73.

    Article  PubMed  CAS  Google Scholar 

  19. Billiard, F., E. Litvinova, D. Saadoun, F. Djelti, D. Klatzmann, J.L. Cohen, G. Marodon, and B.L. Salomon. 2006. Regulatory and effector T cell activation levels are prime determinants of in vivo immune regulation. J Immunol 177:2167–2174.

    PubMed  CAS  Google Scholar 

  20. Nishizuka, Y., and T. Sakakura. 1969. Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 166:753–755.

    Article  PubMed  CAS  Google Scholar 

  21. Sakaguchi, S., K. Fukuma, K. Kuribayashi, and T. Masuda. 1985. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J Exp Med 161:72–87.

    Article  PubMed  CAS  Google Scholar 

  22. Asano, M., M. Toda, N. Sakaguchi, and S. Sakaguchi. 1996. Autoimmune disease as a con sequence of developmental abnormality of a T cell subpopulation. J Exp Med 184:387–396.

    Article  PubMed  CAS  Google Scholar 

  23. Suri-payer, E., A.Z. Amar, A.M. Thornton, and E.M. Shevach. 1998. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 160:1212–1218.

    PubMed  CAS  Google Scholar 

  24. Powrie, F., R. Correa-oliveira, S. Mauze, and R.L. Coffman. 1994. Regulatory interactions between CD45R Bhigh and CD45 RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 179:589–600.

    Article  PubMed  CAS  Google Scholar 

  25. Stephens, L.A., C. Mottet, D. Mason, and F. Powrie. 2001. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 31:1247–1254.

    Article  PubMed  CAS  Google Scholar 

  26. Fontenot, J.D., M.A. Gavin, and A.Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4:330–336.

    Article  PubMed  CAS  Google Scholar 

  27. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057–1061.

    Article  PubMed  CAS  Google Scholar 

  28. Khattri, R., T. Cox, S.A. Yasayko, and F. Ramsdell. 2003. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4:337–342.

    Article  PubMed  CAS  Google Scholar 

  29. Wildin, R.S., S. Smyk-Pearson, and A.H. Filipovich. 2002. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 39:537–545.

    Article  PubMed  CAS  Google Scholar 

  30. Salomon, B., D.J. Lenschow, L. Rhee, N. Ashourian, B. Singh, A. Sharpe, and J.A. Bluestone. 2000. B7/CD28 Costimu lation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431–440.

    Article  PubMed  CAS  Google Scholar 

  31. Seddon, B., and D. Mason. 1999. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J Exp Med 189:877–882.

    Article  PubMed  CAS  Google Scholar 

  32. Jordan, M.S., A. Boesteanu, A.J. Reed, A.L. Petrone, A.E. Holenbeck, M.A. Lerman, A. Naji, and A.J. Caton. 2001. Thymic selection of CD4(+)CD25(+) regulatory T cells induced by an agonist self-peptide. Nat Immunol 2:301–306.

    Article  PubMed  CAS  Google Scholar 

  33. Knoechel, B., J. Lohr, E. Kahn, J.A. Bluestone, and A.K. Abbas. 2005. Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endo genous systemic antigen. J Exp Med 202:1375–1386.

    Article  PubMed  CAS  Google Scholar 

  34. Apostolou, I., and H. von Boehmer. 2004. In vivo instruction of suppressor commitment in naive T cells. J Exp Med 199:1401–1408.

    Article  PubMed  CAS  Google Scholar 

  35. Kretschmer, K., I. Apostolou, D. Hawiger, K. Khazaie, M.C. Nussenzweig, and H. von Boehmer. 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6:1219–1227.

    Article  PubMed  CAS  Google Scholar 

  36. Mucida, D., N. Kutchukhidze, A. Erazo, M. Russo, J.J. Lafaille, and M.A. Curotto de Lafaille. 2005. Oral tolerance in the absence of naturally occurring Tregs. J Clin Invest 115:1923–1933.

    Article  PubMed  CAS  Google Scholar 

  37. You, S., N. Thieblemont, M.A. Alyanakian, J.F. Bach, and L. Chatenoud. 2006. Trans for ming growth factor-beta and T-cell-mediated immunoregulation in the control of autoimmune diabetes. Immunol Rev 212:185–202.

    Article  PubMed  CAS  Google Scholar 

  38. Curotto de Lafaille, M.A., N. Kutchukhidze, S. Shen, Y. Ding, H. Yee, and J.J. Lafaille. 2008. Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 29:114–126.

    Article  PubMed  CAS  Google Scholar 

  39. Liu, V.C., L.Y. Wong, T. Jang, A.H. Shah, I. Park, X. Yang, Q. Zhang, S. Lonning, B.A. Teicher, and C. Lee. 2007. Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta. J Immunol 178:2883–2892.

    PubMed  CAS  Google Scholar 

  40. Sun, C.M., J.A. Hall, R.B. Blank, N. Bouladoux, M. Oukka, J.R. Mora, and Y. Belkaid. 2007. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 204:1775–1785.

    Article  PubMed  CAS  Google Scholar 

  41. Barnes, M.J., and F. Powrie. 2009. Regula tory T cells reinforce intestinal homeostasis. Immunity 31:401–411.

    Article  PubMed  CAS  Google Scholar 

  42. Josefowicz, S.Z., and A. Rudensky. 2009. Control of regulatory T cell lineage commitment and maintenance. Immunity 30:616–625.

    Article  PubMed  CAS  Google Scholar 

  43. Ochi, H., M. Abraham, H. Ishikawa, D. Frenkel, K. Yang, A.S. Basso, H. Wu, M.L. Chen, R. Gandhi, A. Miller, R. Maron, and H.L. Weiner. 2006. Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4(+)CD25(-)LAP(+) T cells. Nat Med 12:627–635.

    Article  PubMed  CAS  Google Scholar 

  44. Chen, M.L., B.S. Yan, Y. Bando, V.K. Kuchroo, and H.L. Weiner. 2008. Latency-associated peptide identifies a novel CD4+CD25+ regulatory T cell subset with TGFbeta-mediated function and enhanced suppression of experimental autoimmune encephalomyelitis. J Immunol 180:7327–7337.

    PubMed  CAS  Google Scholar 

  45. Tang, Q., K.J. Henriksen, M. Bi, E.B. Finger, G. Szot, J. Ye, E.L. Masteller, H. McDevitt, M. Bonyhadi, and J.A. Bluestone. 2004. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 199:1455–1465.

    Article  PubMed  CAS  Google Scholar 

  46. Battaglia, M., A. Stabilini, E. Draghici, B. Migliavacca, S. Gregori, E. Bonifacio, and M.G. Roncarolo. 2006. Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells. Diabetes 55:1571–1580.

    Article  PubMed  CAS  Google Scholar 

  47. Groux, H., A. O’garra, M. Bigler, M. Rouleau, S. Antonenko, J.E. De Vries, and M.G. Roncarolo. 1997. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737–742.

    Article  PubMed  CAS  Google Scholar 

  48. Battaglia, M., S. Gregori, R. Bacchetta, and M.G. Roncarolo. 2006. Tr1 cells: from discovery to their clinical application. Semin Immunol 18:120–127.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. INSERM U1013, Faculté Paris Descartes, Hôpital Necker-Enfants Malades, Paris, France

    Lucienne Chatenoud

Authors
  1. Lucienne Chatenoud
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. CHUHotel Dieu, INSERM UMR 643, Bd. Jean Monnet 30, Nantes, 44093, France

    Maria Cristina Cuturi

  2. CHU Hotel Dieu, INSERM UMR 643, Bd. Jean Monnet 30, Nantes, 44093, France

    Ignacio Anegon

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Humana Press

About this protocol

Cite this protocol

Chatenoud, L. (2010). Natural and Induced T CD4+CD25+FOXP3+ Regulatory T Cells. In: Cuturi, M., Anegon, I. (eds) Suppression and Regulation of Immune Responses. Methods in Molecular Biology, vol 677. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-869-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-869-0_1

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-868-3

  • Online ISBN: 978-1-60761-869-0

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation